Nevertheless, in a recent meta-analysis of randomized controlled studies that examined the effects of CPAP on glycemic control measurements, CPAP does not show decreases in HbA1c level or body mass indices in patients with SAS and type 2 DM, but it does show improved insulin sensitivity [102]. The gene discussed is INS; the disease is SATB2 associated disorder.